T1	intervention 0 26	Hypofractionated radiation
T2	total-participants 868 892	One hundred thirty-three
T9	iv-bin-abs 963 968	Three
T10	outcome 984 1000	local recurrence
T11	outcome 1032 1069	5-year local recurrence-free survival
T12	iv-bin-percent 1073 1078	97.6%
T13	outcome 1080 1106	Five-year overall survival
T14	outcome 1111 1140	5-year breast cancer survival
T15	iv-bin-percent 1146 1151	74.7%
T16	iv-bin-percent 1156 1161	77.7%
T17	outcome 1274 1295	grade 2 skin toxicity
T18	iv-bin-percent 1300 1305	10.7%
T19	iv-bin-abs 1311 1313	no
T20	outcome 1335 1356	grade 3 skin toxicity
T3	eligibility 664 688	post-mastectomy patients
T4	outcome 1204 1220	acute toxicities
